SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medical Industries Of America, MIOA

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Miller who wrote (372)10/20/1997 4:10:00 PM
From: Jamessmith   of 570
 
To ALL: The S Regulatin deal was offered by the previous managment. If I am right, the company has received $1.50 for each convertible share before. It's no doubt it is bad to our investors, as indicated by the new management who has assured no more S Regulation, period.

Though I can take a 30% profit now, I am not going to do so. Because I am always looking into the future of a company, not the past when I invest a company. Even with 10 MM outstanding shares, the company is confident to make $5 MM net income ($0.50/share) next 12 months. As the average of industry PE is 20, I don't see any reasons why MIOA can not reach $5-10.

The company may has also been ready to buy back some stocks, trying to make up for US investors as soon as they finish two acquisions.

Have good luck to all!

James
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext